Spectrum and antibiotic resistance of uropathogens from hospitalised patients with urinary tract infections: 1994-2005
- PMID: 17997282
- DOI: 10.1016/j.ijantimicag.2007.07.029
Spectrum and antibiotic resistance of uropathogens from hospitalised patients with urinary tract infections: 1994-2005
Abstract
From 1994-2005, all uropathogens cultured from the urine of hospitalised urological patients were identified and their sensitivity was tested against the most important antibiotics for the treatment of urinary tract infection (UTI). Duplicate isolates were eliminated. The following results were obtained: (i) there was no general trend of increase in resistance; (ii) certain uropathogens developed resistance to some antibiotics; (iii) vancomycin- or linezolid-resistant staphylococci or enterococci did not play a role; (iv) the lowest overall rates of resistance were found with piperacillin/tazobactam; and (v) ciprofloxacin and trimethoprim/sulfamethoxazole showed the next favourable overall activity. Adequate initial antibiotic therapy is critical in the treatment of severe UTI. Therefore, ongoing surveillance of antibiotic resistance must be performed in every institution. Additionally, it reflects antibiotic and hospital infection policies in a defined department or institution.
Similar articles
-
[Spectrum of pathogens and resistance to antibiotics in urinary tract infections and the consequences for antibiotic treatment: study of urology inpatients with urinary tract infections (1994-2001)].Urologe A. 2003 Jan;42(1):13-25. doi: 10.1007/s00120-002-0265-4. Epub 2002 Dec 19. Urologe A. 2003. PMID: 12574879 German.
-
Spectrum and antibiotic resistance of uropathogens from hospitalized patients with urinary tract infections: 1994-2000.Int J Antimicrob Agents. 2002 Jun;19(6):557-64. doi: 10.1016/s0924-8579(02)00100-0. Int J Antimicrob Agents. 2002. PMID: 12135848
-
Resistance of uropathogens in symptomatic urinary tract infections in León, Nicaragua.Int J Antimicrob Agents. 2004 May;23(5):506-9. doi: 10.1016/j.ijantimicag.2003.10.003. Int J Antimicrob Agents. 2004. PMID: 15120732
-
'Pre-emptive culturing' will improve the chance of 'getting it right' when empirical therapy of urinary tract infections fails.J Antimicrob Chemother. 2009 Aug;64(2):227-8. doi: 10.1093/jac/dkp181. Epub 2009 May 19. J Antimicrob Chemother. 2009. PMID: 19454527 Review.
-
Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.Clin Ther. 2009 Jan;31(1):42-63. doi: 10.1016/j.clinthera.2009.01.013. Clin Ther. 2009. PMID: 19243706 Review.
Cited by
-
Antimicrobial resistance and spread of multi drug resistant Escherichia coli isolates collected from nine urology services in the Euregion Meuse-Rhine.PLoS One. 2012;7(10):e47707. doi: 10.1371/journal.pone.0047707. Epub 2012 Oct 17. PLoS One. 2012. PMID: 23082197 Free PMC article.
-
Urinary tract infections in women: etiology and treatment options.Int J Gen Med. 2011;4:333-43. doi: 10.2147/IJGM.S11767. Epub 2011 Apr 19. Int J Gen Med. 2011. PMID: 21674026 Free PMC article.
-
Transformation of Brevibacillus, a soil microbe to an uropathogen with hemagglutination trait.World J Microbiol Biotechnol. 2014 Jun;30(6):1837-44. doi: 10.1007/s11274-014-1605-4. Epub 2014 Jan 24. World J Microbiol Biotechnol. 2014. PMID: 24464621
-
Urinary bactericidal activity of Doripenem versus that of levofloxacin in patients with complicated urinary tract infections or pyelonephritis.Antimicrob Agents Chemother. 2009 Apr;53(4):1567-73. doi: 10.1128/AAC.01133-08. Epub 2009 Feb 2. Antimicrob Agents Chemother. 2009. PMID: 19188391 Free PMC article. Clinical Trial.
-
Spectrum and Antibiotic Resistance of Uropathogens in Romanian Females.Antibiotics (Basel). 2020 Aug 1;9(8):472. doi: 10.3390/antibiotics9080472. Antibiotics (Basel). 2020. PMID: 32752222 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical